COMT Val 108/158 Met polymorphism and treatment response to aripiprazole in patients with acute schizophrenia

References

• ZhangJPLenczTMalhotraAKD2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysisAm J Psychiatry2010167776377220194480
   PubMed Web of Science ®Google Scholar
• ArranzMJMunroJShamPMeta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine responseSchizophr Res199832293999713904
   PubMed Web of Science ®Google Scholar
• TakekitaYFabbriCKatoMHTR1A polymorphisms and clinical efficacy of antipsychotic drug treatment in schizophrenia: a meta-analysisInt J Neuropsychopharmacol2016195 pii: pyv125
   Web of Science ®Google Scholar
• HuangEZaiCCLisowayACatechol-O-methyltransferase Val158Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizo-affective disorder patients: a meta-analysisInt J Neuropsychopharmacol2016195 pii: pyv132
   Web of Science ®Google Scholar
• BakerKBaldewegTSivagnanasundaramSScamblerPSkuseDCOMT Val108/158Met modifies mismatch negativity and cognitive function in 22q11 deletion syndromeBiol Psychiatry2005581233115935994
   PubMed Web of Science ®Google Scholar
• WooJMYoonKSYuBHCatechol O-methyltransferase genetic polymorphism in panic disorderAm J Psychiatry2002159101785178712359690
   PubMed Web of Science ®Google Scholar
• BertolinoACaforioGBlasiGInteraction of COMT Val108/158 Met genotype and olanzapine treatment on prefrontal cortical function in patients with schizophreniaAm J Psychiatry2004161101798180515465976
   PubMed Web of Science ®Google Scholar
• BertolinoACaforioGBlasiGCOMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophreniaSchizophr Res2007951–325325517644310
   PubMed Web of Science ®Google Scholar
• WeickertWTGoldbergETMisharaACatechol-O-methyltransferase Val108/158Met genotype predicts working memory response to antipsychotic medicationsBiol Psychiatry200456967768215522252
   PubMed Web of Science ®Google Scholar
• WoodwardNDJayathilakeKMeltzerHYCOMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophreniaSchizophr Res2007901–3869617123785
   PubMed Web of Science ®Google Scholar
• YamanouchiYIwataNSuzukiTKitajimaTIkedaMOzakiNEffect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidonePharmacogenomics J20033635636114610521
   PubMed Web of Science ®Google Scholar
• Pelayo-TeránJMPérez-IglesiasRVázquez-BourgonJCatechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosisPsychiatry Res20111851–228628920591499
   PubMed Web of Science ®Google Scholar
• TyburaPSamochowiecABeszlejASome dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patientsPharmacol Rep201264352853522814006
   PubMed Web of Science ®Google Scholar
• BishopJRReillyJLHarrisMSPharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophreniaPsychopharmacology (Berl)2015232114515425096017
   PubMed Web of Science ®Google Scholar
• MaasJWHattoxSEGreeneNMLandisDHEstimates of dopamine and serotonin synthesis by the awake human brainJ Neurochem1980346154715496155442
   PubMed Web of Science ®Google Scholar
• KopinIJGordonEKJimersonDCPolinskyRJRelation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycolScience1983219458073756849119
   PubMed Web of Science ®Google Scholar
• MiuraITakeuchiSKatsumiAEffects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophreniaJ Clin Psychopharmacol201232110610922198450
   PubMed Web of Science ®Google Scholar
• NagaokaSIwamotoNAraiHFirst-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatmentBiol Psychiatry19974188578649099412
   PubMed Web of Science ®Google Scholar
• WatanabeKMiuraIKanno-NozakiKAssociations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophreniaPsychiatry Res2015230241942326416588
   PubMed Web of Science ®Google Scholar
• LiTShamPCValladaHPreferential transmission of the high activity allele of COMT in schizophreniaPsychiatr Genet1996631311338902889
   PubMed Web of Science ®Google Scholar
• WilliamsGVCastnerSAUnder the curve: critical issues for elucidating D1 receptor function in working memoryNeuroscience2006139126327616310964
   PubMed Web of Science ®Google Scholar
• JönssonEGGoldmanDSpurlockGTryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteersEur Arch Psychiatry Clin Neurosci199724762973029477008
   PubMed Web of Science ®Google Scholar
• ZalsmanGHuangYYHarkavy-FriedmanJMOquendoMAEllisSPMannJJRelationship of MAO-A promoter (u-VNTR) and COMT (V158M) gene polymorphisms to CSF monoamine metabolites levels in a psychiatric sample of caucasians: a preliminary reportAm J Med Genet B Neuropsychiatr Genet2005132B110010315457497
   PubMed Web of Science ®Google Scholar
• AndreouDSödermanEAxelssonTPolymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosisBehav Brain Funct2014102625073638
   PubMed Web of Science ®Google Scholar
• KöhnkeMDWiatrGKolbWPlasma homovanillic acid: a significant association with alcoholism is independent of a functional polymorphism of the human catechol-O-methyltransferase geneNeuropsychopharmacology20032851004101012741370
   PubMed Web of Science ®Google Scholar
• DávilaRZumárragaMBasterrecheNArrúeAZamalloaMIAnguianoJBInfluence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder – a preliminary reportJ Affect Disord2006922–327728116542735
   PubMed Web of Science ®Google Scholar
• BasterrecheNDávilaRZumárragaMBiological correlates of the congruence and incongruence of psychotic symptoms in patients with type 1 bipolar disorderNeuropsychobiology2008583–411111718997477
   PubMed Web of Science ®Google Scholar
• MiuraIKanno-NozakiKHinoMInfluence of -141C Ins/Del polymorphism in DRD2 gene on clinical symptoms and plasma homovanillic acid levels in the treatment of schizophrenia with aripiprazoleJ Clin Psychopharmacol201535333333425871573
   PubMed Web of Science ®Google Scholar